首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
【2h】

Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.

机译:比较一种新型的含甲氧苄氨嘧啶磺胺甲基异恶唑的培养基(XT80)与卡那霉素琼脂的比较从骨髓移植患者的粪便和直肠培养物中分离出耐药菌。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A new medium (XT80) containing trimethoprim-sulfamethoxazole (TMP-SMZ) was characterized and compared with kanamycin-containing tryptic soy agar (KA) for the recovery of multiply resistant organisms (MRO) in rectal and stool cultures. Cultures from 151 patients hospitalized for bone marrow transplantation were screened for MRO. A total of 366 MRO were recovered from 702 cultures on 94 patients during a 6-month period. XT80 detected more gram-negative bacilli and Corynebacterium spp. than KA. Detection of Staphylococcus spp. was equivalent for the two media. Multiple-antibiotic resistance, defined as resistance to three or more classes of antibiotics, was confirmed by standard agar disk diffusion susceptibility testing. Growth on XT80 correctly identified heteroresistant strains of methicillin-resistant Staphylococcus spp. XT80 more rapidly detected thymidine-dependent mutants of Staphylococcus spp. and members of the family Enterobacteriaceae. Lipophilic Corynebacterium spp., including Corynebacterium group JK, also were more readily detected with XT80. TMP-SMZ given as prophylaxis against Pneumocystis carinii infection exerts a selective pressure on organisms that colonize immunocompromised patients and appears to select for colonization with MRO. Colonization with MRO preceded infection for 94% of 36 patients who developed bacteremia. XT80 is a useful screening tool; growth on this medium correlates closely with resistance to TMP-SMZ and is as accurate a predictor as KA for the carriage of MRO.
机译:表征了一种新的培养基(XT80),其中含有甲氧苄啶-磺胺甲基恶唑(TMP-SMZ),并与含卡那霉素的胰蛋白酶大豆琼脂(KA)进行了比较,以回收直肠和粪便培养物中的多重耐药菌(MRO)。从151例住院的骨髓移植患者中筛选培养物的MRO。在6个月内,共从94位患者的702种培养物中回收了366种MRO。 XT80检测到更多的革兰氏阴性杆菌和棒状杆菌属。比KA金黄色葡萄球菌的检测。对于两种媒体来说是等效的。通过标准琼脂圆盘扩散敏感性测试证实了多重抗生素耐药性,定义为对三种或三种以上抗生素的耐药性。在XT80上的生长正确鉴定了耐甲氧西林葡萄球菌属的杂种菌株。 XT80更快速地检测到葡萄球菌属物种的胸苷依赖性突变体。和肠杆菌科的成员。 XT80也更容易检测到亲脂性棒状杆菌属菌,包括棒状杆菌JK组。预防卡氏肺孢子虫感染的TMP-SMZ对定居免疫受损患者的生物体施加了选择性压力,并似乎选择了MRO定植。在发生菌血症的36名患者中,有94%的患者在感染前先进行MRO定植。 XT80是有用的筛选工具;在这种培养基上的生长与对TMP-SMZ的抗性密切相关,并且与运送MRO的KA一样准确。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号